![OGSIVEO FDA-Approval Featured Image](https://dtrf.org/wp-content/uploads/2023/11/breaking-news-niro-FDA-approval-featured-image-2-720x450.png)
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
![](https://dtrf.org/wp-content/uploads/2023/09/DTRF-Wins-Global-Genes-Award_Champions-of-Hope_Newsroom-720x450.jpg)
November 19, 2021
DTRF Receives Global Genes Champions Of Hope “Rare Champion In Advocacy (Foundation)” Award
![](https://dtrf.org/wp-content/uploads/2023/09/molecule-2082634_1280_Newsroom-720x450.jpg)
October 26, 2021
Breaking News: DTRF-Funded Research Results In Two Stable Desmoid Tumor Cell Lines
Read More about Breaking News: DTRF-Funded Research Results In Two Stable Desmoid Tumor Cell Lines
![](https://dtrf.org/wp-content/uploads/2023/09/ICD-10-Codes_shutterstock_588071342_Newsroom-720x450.jpg)
October 4, 2021
Update: DTRF Submits Proposal To CDC For Specific ICD-10 Code For Desmoid Tumors
Read More about Update: DTRF Submits Proposal To CDC For Specific ICD-10 Code For Desmoid Tumors
![](https://dtrf.org/wp-content/uploads/2023/09/FINAL_DTAM-2021_Standard-Promo-Image_TW_Newsroom-720x450.jpg)
September 30, 2021
Desmoid Tumor Awareness Month 2021 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2021 Comes To A Close
![](https://dtrf.org/wp-content/uploads/2023/09/END-and-Thank-you_Logo-only_TW_Newsroom-720x450.png)
September 27, 2021
DTRF Hosts Successful 2021 Virtual DTRF “Together We Will” Weekend
Read More about DTRF Hosts Successful 2021 Virtual DTRF “Together We Will” Weekend
![](https://dtrf.org/wp-content/uploads/2023/09/Rare-Impact-Awards_Custom-promo-image_TW_Newsroom-720x450.png)
March 3, 2021
DTRF Awarded The 2021 “Abbey S. Meyers Leadership Award”, A Nord “Rare Impact Award”
Read More about DTRF Awarded The 2021 “Abbey S. Meyers Leadership Award”, A Nord “Rare Impact Award”